Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Myelodysplastic Syndromes 101Lymphoma, Non-Hodgkin 94Leukemia, Lymphocytic, Chronic, B-Cell 94Hodgkin Disease 88Multiple Myeloma 82Leukemia 73Lymphoma, Mantle-Cell 63Lymphoma, Follicular 62Lymphoma 62Lymphoma, Large B-Cell, Diffuse 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54Burkitt Lymphoma 50Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 42Leukemia, Myeloid, Accelerated Phase 39Anemia, Refractory, with Excess of Blasts 36Hematologic Neoplasms 35Waldenstrom Macroglobulinemia 34Primary Myelofibrosis 34Graft vs Host Disease 34Blast Crisis 31Neoplasms, Plasma Cell 30Recurrence 28Dendritic Cell Sarcoma, Interdigitating 28

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-Malignant Neoplasm × Mycophenolic Acid × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡